{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,10,5]],"date-time":"2026-10-05T09:30:29Z","timestamp":1791192629162,"version":"4.1.0"},"reference-count":21,"publisher":"American Society of Hematology","issue":"5","content-domain":{"domain":["ashpublications.org"],"crossmark-restriction":true},"short-container-title":[],"published-print":{"date-parts":[[2005,3,1]]},"abstract":"<jats:title>Abstract<\/jats:title>\n               <jats:p>Chromosomal translocations juxtaposing immunoglobulin (Ig) and MYC genes are the hallmarks of human Burkitt lymphoma (BL), with deregulated MYC expression being a critical factor in pathogenesis. By inserting an intact mouse Myc gene into the mouse genome, proximal to the Ig enhancer E\u03bc, the effect of a precise mimic of the major t(8;14) translocation of human endemic BL (eBL) could be investigated. Knock-in mice developed IgM-positive B-cell tumors, with most being typical of eBL by histology and immunophenotype, including expression of the germinal center (GC)\u2013associated protein, BCL6. Unlike eBL, however, analysis of Ig VH sequences revealed no significant level of somatic mutation. Thus, constitutive expression of Myc in the knock-in mice is apparently able to induce \u201cBurkitt-like\u201d lymphomas before antigen stimulation and formation of a GC. In contrast, human eBL development occurs in a GC or post-GC site with a likely contribution to pathogenesis from Epstein-Barr virus (EBV) and other epigenetic factors.<\/jats:p>","DOI":"10.1182\/blood-2004-07-2573","type":"journal-article","created":{"date-parts":[[2004,11,3]],"date-time":"2004-11-03T03:08:50Z","timestamp":1099451330000},"page":"2135-2137","update-policy":"https:\/\/doi.org\/10.1182\/blood.2019cm0000","source":"Crossref","is-referenced-by-count":31,"title":["Deregulated expression of the Myc cellular oncogene drives development of mouse \u201cBurkitt-like\u201d lymphomas from naive B cells"],"prefix":"10.1182","volume":"105","author":[{"given":"Delin","family":"Zhu","sequence":"first","affiliation":[{"name":"From the Molecular Immunology Group, Tenovus Laboratory, Southampton University Hospitals Trust, United Kingdom; Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and Laboratory of Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Chen Feng","family":"Qi","sequence":"additional","affiliation":[{"name":"From the Molecular Immunology Group, Tenovus Laboratory, Southampton University Hospitals Trust, United Kingdom; Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and Laboratory of Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"suffix":"III","given":"Herbert C.","family":"Morse","sequence":"additional","affiliation":[{"name":"From the Molecular Immunology Group, Tenovus Laboratory, Southampton University Hospitals Trust, United Kingdom; Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and Laboratory of Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siegfried","family":"Janz","sequence":"additional","affiliation":[{"name":"From the Molecular Immunology Group, Tenovus Laboratory, Southampton University Hospitals Trust, United Kingdom; Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and Laboratory of Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Freda K.","family":"Stevenson","sequence":"additional","affiliation":[{"name":"From the Molecular Immunology Group, Tenovus Laboratory, Southampton University Hospitals Trust, United Kingdom; Laboratory of Immunopathology, National Institute of Allergy and Infectious Diseases, National Institutes of Health, Bethesda, MD; and Laboratory of Genetics, National Cancer Institute, National Institutes of Health, Bethesda, MD."}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"234","reference":[{"key":"2020021222231108700_REF1","doi-asserted-by":"crossref","unstructured":"Dalla-Favera R, Bregni M, Erikson J, Patterson D, Gallo RC, Croce CM. Human c-myc onc gene is located on the region of chromosome 8 that is translocated in Burkitt lymphoma cells. Proc Natl Acad Sci U S A. 1982;79: 7824-7827.","DOI":"10.1073\/pnas.79.24.7824"},{"key":"2020021222231108700_REF2","doi-asserted-by":"crossref","unstructured":"Taub R, Kirsch I, Morton C, et al. Translocation of the c-myc gene into the immunoglobulin heavy chain locus in human Burkitt lymphoma and murine plasmacytoma cells. Proc Natl Acad Sci U S A. 1982;79: 7837-7841.","DOI":"10.1073\/pnas.79.24.7837"},{"key":"2020021222231108700_REF3","doi-asserted-by":"crossref","unstructured":"Boxer LM, Dang CV. Translocations involving c-myc and c-myc function. Oncogene. 2001;20: 5595-5610.","DOI":"10.1038\/sj.onc.1204595"},{"key":"2020021222231108700_REF4","doi-asserted-by":"crossref","unstructured":"Kovalchuk AL, Qi CF, Torrey TA, et al. Burkitt lymphoma in the mouse. J Exp Med. 2000;192: 1183-1190.","DOI":"10.1084\/jem.192.8.1183"},{"key":"2020021222231108700_REF5","doi-asserted-by":"crossref","unstructured":"Chapman CJ, Wright D, Stevenson FK. Insight into Burkitt's lymphoma from immunoglobulin variable region gene analysis. Leuk Lymphoma. 1998;30: 257-267.","DOI":"10.3109\/10428199809057539"},{"key":"2020021222231108700_REF6","doi-asserted-by":"crossref","unstructured":"Adams JM, Harris AW, Pinkert CA, et al. The c-myc oncogene driven by immunoglobulin enhancers induces lymphoid malignancy in transgenic mice. Nature. 1985;318: 533-538.","DOI":"10.1038\/318533a0"},{"key":"2020021222231108700_REF7","doi-asserted-by":"crossref","unstructured":"Zhu D, van Arkel C, King CA, et al. Immunoglobulin VH gene sequence analysis of spontaneous murine immunoglobulin-secreting B-cell tumours with clinical features of human disease. Immunology. 1998;93: 162-170.","DOI":"10.1046\/j.1365-2567.1998.00428.x"},{"key":"2020021222231108700_REF8","doi-asserted-by":"crossref","unstructured":"Magrath IT. African Burkitt's lymphoma: history, biology, clinical features, and treatment. Am J Pediatr Hematol Oncol. 1991;13: 222-246.","DOI":"10.1097\/00043426-199122000-00019"},{"key":"2020021222231108700_REF9","doi-asserted-by":"crossref","unstructured":"Cattoretti G, Chang CC, Cechova K, et al. BCL-6 protein is expressed in germinal-center B cells. Blood. 1995;86: 45-53.","DOI":"10.1182\/blood.V86.1.45.bloodjournal86145"},{"key":"2020021222231108700_REF10","doi-asserted-by":"crossref","unstructured":"Niu H. The proto-oncogene BCL-6 in normal and malignant B cell development. Hematol Oncol. 2002;20: 155-166.","DOI":"10.1002\/hon.689"},{"key":"2020021222231108700_REF11","doi-asserted-by":"crossref","unstructured":"Polack A, Hortnagel K, Pajic A, et al. c-myc activation renders proliferation of Epstein-Barr virus (EBV)-transformed cells independent of EBV nuclear antigen 2 and latent membrane protein 1. Proc Natl Acad Sci U S A. 1996;93: 10411-10416.","DOI":"10.1073\/pnas.93.19.10411"},{"key":"2020021222231108700_REF12","doi-asserted-by":"crossref","unstructured":"Pajic A, Staege MS, Dudziak D, et al. Antagonistic effects of c-myc and Epstein-Barr virus latent genes on the phenotype of human B cells. Int J Cancer. 2001;93: 810-816.","DOI":"10.1002\/ijc.1404"},{"key":"2020021222231108700_REF13","doi-asserted-by":"crossref","unstructured":"Stevenson FK, Sahota SS, Ottensmeier CH, Zhu D, Forconi F, Hamblin TJ. The occurrence and significance of V gene mutations in B cell-derived human malignancy. Adv Cancer Res. 2001;83: 81-116.","DOI":"10.1016\/S0065-230X(01)83004-9"},{"key":"2020021222231108700_REF14","doi-asserted-by":"crossref","unstructured":"Damle RN, Wasil T, Fais F, et al. Ig V gene mutation status and CD38 expression as novel prognostic indicators in chronic lymphocytic leukemia. Blood. 1999;94: 1840-1847.","DOI":"10.1182\/blood.V94.6.1840"},{"key":"2020021222231108700_REF15","doi-asserted-by":"crossref","unstructured":"Hamblin TJ, Davis Z, Gardiner A, Oscier DG, Stevenson FK. Unmutated Ig VH genes are associated with a more aggressive form of chronic lymphocytic leukemia. Blood. 1999;94: 1848-1854.","DOI":"10.1182\/blood.V94.6.1848"},{"key":"2020021222231108700_REF16","doi-asserted-by":"crossref","unstructured":"Haluska FG, Finver S, Tsujimoto Y, Croce CM. The t(8; 14) chromosomal translocation occurring in B-cell malignancies results from mistakes in V-D-J joining. Nature. 1986;324: 158-161.","DOI":"10.1038\/324158a0"},{"key":"2020021222231108700_REF17","doi-asserted-by":"crossref","unstructured":"Kuppers R, Dalla-Favera R. Mechanisms of chromosomal translocations in B cell lymphomas. Oncogene. 2001;20: 5580-5594.","DOI":"10.1038\/sj.onc.1204640"},{"key":"2020021222231108700_REF18","doi-asserted-by":"crossref","unstructured":"Zhu D, McCarthy H, Ottensmeier CH, Johnson P, Hamblin TJ, Stevenson FK. Acquisition of potential N-glycosylation sites in the immunoglobulin variable region by somatic mutation is a distinctive feature of follicular lymphoma. Blood. 2002; 99: 2562-2568.","DOI":"10.1182\/blood.V99.7.2562"},{"key":"2020021222231108700_REF19","doi-asserted-by":"crossref","unstructured":"Zhu D, Ottensmeier CH, Du MQ, McCarthy H, Stevenson FK. Incidence of potential glycosylation sites in immunoglobulin variable regions distinguishes between subsets of Burkitt's lymphoma and mucosa-associated lymphoid tissue lymphoma. Br J Haematol. 2003;120: 217-222.","DOI":"10.1046\/j.1365-2141.2003.04064.x"},{"key":"2020021222231108700_REF20","doi-asserted-by":"crossref","unstructured":"Hochberg D, Middeldorp JM, Catalina M, Sullivan JL, Luzuriaga K, Thorley-Lawson DA. Demonstration of the Burkitt's lymphoma Epstein-Barr virus phenotype in dividing latently infected memory cells in vivo. Proc Natl Acad Sci U S A. 2004;101: 239-244.","DOI":"10.1073\/pnas.2237267100"},{"key":"2020021222231108700_REF21","unstructured":"Park SS, Kim JS, Tessarollo L, et al. Insertion of c-Myc into IgH induces B-cell and plasma-cell neoplasms in mice. Cancer Res. In press."}],"container-title":["Blood"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/5\/2135\/1706769\/zh800505002135.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"syndication"},{"URL":"http:\/\/ashpublications.org\/blood\/article-pdf\/105\/5\/2135\/1706769\/zh800505002135.pdf","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2020,2,13]],"date-time":"2020-02-13T03:23:20Z","timestamp":1581564200000},"score":1,"resource":{"primary":{"URL":"https:\/\/ashpublications.org\/blood\/article\/105\/5\/2135\/20280\/Deregulated-expression-of-the-Myc-cellular"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2005,3,1]]},"references-count":21,"journal-issue":{"issue":"5","published-print":{"date-parts":[[2005,3,1]]}},"URL":"https:\/\/doi.org\/10.1182\/blood-2004-07-2573","relation":{},"ISSN":["0006-4971","1528-0020"],"issn-type":[{"value":"0006-4971","type":"print"},{"value":"1528-0020","type":"electronic"}],"subject":[],"published":{"date-parts":[[2005,3,1]]}}}